118
Participants
Start Date
November 26, 2018
Primary Completion Date
April 1, 2022
Study Completion Date
June 13, 2022
tozuleristide
Tozuleristide will be administered at least 1 hour and no more than 36 hours prior to planned surgical excision of their tumor.
Canvas System
All subjects enrolled in the study will have their tissue imaged with the Canvas System.
Johns Hopkins University, Baltimore
University of Florida Shands Hospital, Gainesville
St. Jude Children's Research Hospital, Memphis
Children's Hospital of Michigan, Detroit
Children's Minnesota, Saint Paul
Washington University St. Louis Children's Hospital, St Louis
Chlidren's Hospital Los Angeles, Los Angeles
University of California, San Francisco, San Francisco
Seattle Children's Hospital, Seattle
Lead Sponsor
Pacific Pediatric Neuro-Oncology Consortium
OTHER
Blaze Bioscience Inc.
INDUSTRY